STREAM is the first large-scale, multi-country clinical trial to investigate shortened regimens for multidrugresistant tuberculosis (MDR-TB), and the first phase III trial to test the efficacy and safety of Bedaquiline, a new drug with a novel mechanism of action, within a shortened treatment regimen.
The trial established a Community Engagement (CE) Plan. The CE program was implemented at thirteen research sites within the STREAM trial, in seven countries. This paper sets out a summary of the experiences of CABs in connection with the STREAM clinical trial. It underlines relevant aspects that may be useful when planning and/or engaging communities in research. In conclusion, the experiences gained during STREAM, lead to both growing confidence in CE as a valuable process and community participation in advocacy.
Recent Abstracts
Strengthening the Civil Registration and Vital Statistics (CRVS) System in Colombia
Estimation of the direct and indirect costs attributable to alcohol consumption in Brazil
Guidance for Collection and Processing of Cause-of-Death Data in the Civil Registration and…
Vital Strategies: Reimagine Public Health
Public perceptions of emissions testing in Jakarta, Indonesia
Cost-Benefit Analysis for Air Pollution Control Strategies in Jakarta
Key Messages on Alcohol Harms and Policy Solutions
Flooding and Early Childhood Development
RESET Alcohol – Public Attitudes Towards Alcohol Policy in Mexico
Estimating the annual production data of bidi sticks in India using the “back-of-the-envelop”…